Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03637881 · ClinicalTrials.gov registry record
Cconsumer Perspective and Understanding of the Term "Milk"
A clinical trial, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.
- Completed
- Registry status
- 42
- Enrollment target
NCT03637881: Completed study, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.
NCT03637881 is a clinical trial that has completed, run by Clinical Nutrition Research Center, Illinois Institute of Technology. The registered enrollment target is 42 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03637881 has completed, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.
- COMPLETED
- Registry status
- 42 participants
- Enrollment target
Study Summary
The objectives of this study are: 1. To determine the consumption behaviors of dairy and non-dairy milks across a diverse demographic. 2. To determine the purchasing behaviors of dairy and non-dairy milks across a diverse demographic. 3. To determine the variation in medical history and health conditions amongst consumers of dairy milk and non-dairy milk alternatives. 4. To assess the general knowledge and awareness of health associated with dairy milk and non-dairy milk alternatives.
Primary Outcome
Consumption behaviors of dairy and non-dairy milks
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2018-07-24 |
| Est. Completion | 2018-08-10 |
What the finished NCT03637881 record still lists
NCT03637881 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 42 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03637881 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03637881 about?
NCT03637881 is a clinical study titled "Cconsumer Perspective and Understanding of the Term "Milk"". The objectives of this study are: 1. To determine the consumption behaviors of dairy and non-dairy milks across a diverse demographic. 2. To determine the purchasing behaviors of dairy and non-dairy milks across a diverse demographic. 3. To determine the variation in medical history and health cond...
What is the current status of trial NCT03637881?
This trial is currently completed. The enrollment target is 42 participants. The study started on 2018-07-24. Estimated completion is 2018-08-10.
Who is sponsoring clinical trial NCT03637881?
This trial is sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI